Furthermore, a combination of curcumin with anti-EGFR (epidermal growth factor receptor) monoclonal antibodies in cutaneous squamous cell carcinoma patients has been shown as a highly effective strategy in disease control in another clinical [88]. This evidence concerns the gene EGFR and cutaneous squamous cell carcinoma.